Drug safety in patients with mitochondrial disease: an observational cohort study

Neurological Sciences · Published 2026-08-06 · DOI 10.1007/s10072-026-09298-5

Free full text

Authors (2)

Oskar Järvinen, Mika H. Martikainen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Järvinen, O., Martikainen, M. (2026). Drug safety in patients with mitochondrial disease: an observational cohort study. Neurological Sciences. https://doi.org/10.1007/s10072-026-09298-5

Related articles

• Accelerated brain aging and anterior white matter hyperintensity burden in chronic post-stroke aphasia: a lesion-aware MRI analysis · Neurological Sciences · 2026 · Same journal
• Generative large language models in the clinical management of Alzheimer’s disease and mild cognitive impairment · Neurological Sciences · 2026 · Same journal
• Device aided therapies in Parkinson disease: an expert view on apomorphine · Neurological Sciences · 2026 · Same journal
• A novel FLNA missense variant in a mother–daughter pair with epilepsy: case series evidence of variable multisystem expressivity · Neurological Sciences · 2026 · Same journal
• A comparison of the effects of greater occipital nerve blockade and combined greater occipital–supraorbital nerve blockade on headache in chronic migraine · Neurological Sciences · 2026 · Same journal
• Temporal enhancement patterns on 3D-FLAIR MRI in labyrinthine infarction · Neurological Sciences · 2026 · Same journal
• Topography and functional connectivity analysis of heart surgery-associated brain lesions: a literature review · Neurological Sciences · 2026 · Same journal
• Relationship between excessive daytime sleepiness and motor subtype transition in untreated prodromal Parkinson’s disease: a cohort study · Neurological Sciences · 2026 · Same journal
• Beyond EDSS: a radar chart approach for multidimensional clinical monitoring in multiple Sclerosis · Neurological Sciences · 2026 · Same journal
• Identification and validation of Parkinson’s disease relevant microRNAs in plasma extracellular vesicles · Neurological Sciences · 2026 · Same journal